The gram-negative bacterial genus Shigella includes the causative agent of bacillary dysentery in humans. The essential steps for Shigella virulence are invasion of epithelial cells, intracellular multiplication, and spread of bacteria into adjacent cells (16) . The invasion ability of shigellae is dependent upon a 31-kb region of the 230-kb virulence plasmid. The common 31-kb region is essential for virulence. This region includes genes for invasins, molecular chaperones, motility, regulation, and a specialized type III secretion system. A similar plasmid is also found in enteroinvasive Escherichia coli strains (10, 11, 14, 20, 28, 29) .
The 31-kb region contains two divergently transcribed loci that encode more than 30 genes. One locus includes the ipaBCD genes for effector molecules and the icsB and ipgC genes, and the other locus includes a cluster of about 20 genes for Mxi and Spa proteins, which are components of the type III secretion system and function in surface presentation and secretion of the IpaBCD effector proteins (1, 2, 3, 31, 36) . Ipa effector proteins act as triggers for entry into epithelial cells and are required for escape from phagosomes (14, 20) . The IpaB protein also has a lysin-like, cytotoxin-like function, by which it lyses vacuole membranes and induces apoptosis of macrophages (38) . The IcsB and IpgC proteins are encoded upstream of the ipa genes. IcsB forms protrusions at the surface of infected cells, and IpgC is a molecular chaperone that associates with IpaB and IpaC in the bacterial cytoplasm. IpgC stabilizes IpaB and IpaC and prevents their premature association (21) . The expression of the icsB-ipa operon region is positively controlled by a regulator cascade composed of InvE (VirB) and VirF, which are encoded on the virulence plasmid (8, 12, 24, 30) .
The primary regulator VirF is an AraC-like transcription factor that activates transcriptional expression of the secondary regulatory gene invE (26) . InvE is required for transcription of the ipa, mxi, and spa operons but a mechanism of activation has not been clarified. When the bacteria encounter a 37°C environment, VirF activates transcription of both icsA and invE, initiating the cascade of virulence gene expression (19, 37) .
InvE protein has been identified as an essential factor for the expression of the virulence genes of Shigella sonnei (37) . InvE has no homology to conventional transcriptional factors. However, InvE has significant homology to the ParB and SopB proteins, which are required for plasmid partitioning and maintenance of plasmid copy number of the P1 and P7 plasmids and F plasmid, respectively. But there are some differences in function between ParB and InvE. ParB is involved in plasmid partitioning, while InvE is probably not, because InvE does not complement a parB mutation (H. Watanabe, unpublished data). ParB autorepresses parAB transcription (15) , while InvE activates the expression of invasion genes. The ParB dimer binds specifically to the parS sequence of plasmid P1. A helix-turn-helix (HTH) region of ParB recognizes the BoxA motifs of the parS site (5, 35) .
The predicted secondary structure of InvE contains two motifs found in transcriptional factors: HTH, and a putative leucine zipper. Beloin et al. reported that the oligomerization of InvE requires the leucine zipper domain and that the ability of InvE to activate virulence gene expression depends on the presence of the HTH motif (4). However, it is not clear how InvE regulates virulence gene expression.
In this study, we focused on identification of the cis element required for activation of expression of the ipa genes by InvE. First, we determined the transcription start site of icsB, which is the leadoff gene of the ipa operon. Then, we confirmed that a glutathione S-transferase (GST)-InvE fusion protein bound specifically to the region around the transcription start site of icsB. Based on these findings, we concluded that the region upstream of the ipa operon is essential for IpaB expression.
MATERIALS AND METHODS
Bacterial strains and plasmids. The bacterial strains and plasmids used in this study are listed in Table 1 . E. coli K-12 CC118 (18) was the host for pSS120 and its derivatives. E. coli MC1061 (34) was the host for overproduction of the GST-InvE fusion protein. Strain HW1273 is an ampicillin-resistant E. coli K-12 strain carrying S. sonnei virulence plasmid pHW1273 (pSS120::Tn1) which was derived from transconjugation of E. coli CC118 with S. sonnei HW383 (37) . Plasmid pHW749, containing virF and invE genes, was used as the source of these activators (37) . Plasmid pJK1142 is a derivative of F plasmid-replicon vector pJK282 carrying a 31-kb region spanning from a part of ipaB to the mxi-spa genes of S. sonnei plasmid (14) . Plasmid pHW735 is a derivative of pJK1142 which has a Tn3-lac insertion in ipaB, which was used for determination of the transcription start site of icsB (37) . In this study, all the experiments were performed in E. coli. We are assuming that the transcriptional signals are well conserved between S. sonnei and E. coli.
Media and buffers. Bacteria were grown according to standard methods in Luria-Bertani (LB) broth (23) or on 1.5% Bacto agar plates, both containing appropriate antibiotics. Antibiotic concentrations were as follows: kanamycin, 40 g/ml; chloramphenicol, 25 g/ml; and ampicillin, 40 g/ml. YENEB (0.75% Bacto yeast extract, 0.8% Bacto nutrient broth) was used for preparation of competent cells (32) . During the course of protein purification, a lysis buffer (1% Triton X-100 and 1 mM phenylmethylsulfonyl fluoride in phosphate-buffered saline [0.8% NaCl, 0.02% KCl, 0.3 mM Na 2 HPO 4 , and 0.15 mM KH 2 PO4]) was used for the bacterial suspension step. For dilution of protein samples, we used an elution buffer consisting of 50 mM Tris-HCl (pH 7.8) containing 10 mM reduced glutathione.
Preparation and manipulation of DNA. Preparation and manipulation of DNA were carried out essentially as described by Maniatis et al. (17) .
RNA preparation and primer extension. Total cellular RNA was extracted from E. coli K-12 MC1061 harboring pHW735 and pHW735 or pHW749 in order to study transcription of icsB. RNA was prepared essentially as described by Chomczynski and Sacchi (6) . Bacterial cultures were grown with shaking at 37°C in 40 ml of LB medium overnight. RNA samples from each culture were prepared with Isogen (Nippon Gene, Tokyo, Japan) according to the manufacturer's instructions, and the RNA was quantified by measuring the absorbance at 260 nm (A 260 ). The RNA sample was dissolved in H 2 O and stored at Ϫ70°C.
For the primer extension assay, we used a synthetic primer (5Ј-GAGGATCA TACTTTATTAACTC-3Ј, complementary to nucleotides 126 to 147 in Fig. 1 ) that had been 5Ј-end labeled with [␥-32 P]ATP (specific activity, Ͼ3,000 Ci/mmol; Amersham United Kingdom) with T4 polynucleotide kinase (Megalabel; Takara, Tokyo, Japan). Total RNA (20 g) was annealed to 1.0 pmol of 5Ј-end-labeled primer at 80°C for 2 min and then at 42°C for 45 min in 50 l of buffer containing 100 mM Tris-HCl (pH 7.5), 100 mM KCl, and 20 mM MgCl 2 . Then, the four deoxynucleoside triphosphates, dithiothreitol, and reverse transcriptase from avian sarcoma-related virus (Takara, Tokyo, Japan) were added to the solution at final concentrations of 2 mM each, 1 mM, and 20 U per 50 l, respectively. The reaction was continued for 1 h at 42°C. The synthesized DNA was extracted with phenol-chloroform, precipitated with ethanol, dissolved in DNA sequencing solution (27) , and analyzed by electrophoresis on an 8% polyacrylamide gel containing 8.3 M urea, followed by autoradiography. As a standard, the above 32 P-labeled primer was annealed to alkaline-denatured DNA from pHW735, and a dideoxy chain termination sequencing reaction was amplified with Klenow enzyme, as described elsewhere (27) . The samples were loaded on the gel with the synthesized DNA described above.
Construction of promoter deletion mutants by a PCR-based gene disruption pHW1273 with region upstream of icsB promote deleted from Ϫ1740 to Ϫ136 (using primers H2 and H5 for disruption; see Table 2 ) This study pTT0818 pHW1273 with region upstream of icsB promoter deleted from Ϫ1740 to Ϫ41 (using primers H2 and H6 for disruption; see Table 2 ) This study pTT1405 pHW1273 with region upstream of icsB promoter deleted from Ϫ1740 to Ϫ74 (using the primers H2 and H10 for disruption; see Table 2 ) This study pTT1608 pHW1273 with region upstream of icsB promoter deleted from Ϫ1740 to Ϫ84 (using primers H2 and H11 for disruption; see Table 2 ) This study pTT1804 pHW1273 with region upstream of icsB promoter deleted from Ϫ1740 to Ϫ94 (using primers H2 and H12 for disruption; see Table 2 ) This study pTT2002 pHW1273 with region upstream of icsB promoter deleted from Ϫ1740 to Ϫ104 (using primers H2 and H13 for disruption; see Table 2 ) This study pTT2201 pHW1273 with region upstream of icsB promoter deleted from Ϫ1740 to Ϫ85 (using primers H2 and H13-1 for disruption; see Table 2 ) This study pTT2202 pHW1273 with region upstream of icsB promoter deleted from Ϫ1740 to Ϫ86 (using primers H2 and H13-2 for disruption; see Table 2 ) This study pTT2203 pHW1273 with region upstream of icsB promoter deleted from Ϫ1740 to Ϫ87 (using primers H2 and H13-3 for disruption; see (7). For construction of the deletion series, the PCR-based gene disruption method with Red recombinase (7) was used with some modifications. Because strain HW1273 is ampicillin resistant, the bla gene of plasmid pKD46 (7) was exchanged with cat by an in vitro transposase reaction with the GPS-LS kit (New England Biolabs). The resultant plasmid was designated pKD46::Cm.
Strain HW1273 with Red helper plasmid (pKD46::Cm) was grown in 5-ml YENB cultures with chloramphenicol and 10 mM L-arabinose at 30°C to an optical density at 600 nm of 0.6 and was then made electrocompetent by concentrating the bacteria 100-fold and washing three times with ice-cold distilled water (7). Next, linear DNA for the construction of deletion mutants was synthesized by PCR. PCR primers ( Table 2 .) were about 70-bp single-stranded DNAs corresponding to the sites which flank the upstream regions of the icsB promoter to be deleted and the kanamycin resistance gene of pKD13. Plasmid pKD13 was used as a template DNA for PCR to introduce a kanamycin resistance cassette with the FLP recognition target (FRT) sequence at the both ends of the kanamycin resistance gene. PCR products were purified and suspended in distilled water. Transformation was performed by electroporation with 50 l of competent cells (HW1273 carrying pKD46::Cm) prepared as described above and 100 ng of the linear PCR product. Shocked cells were added to 1 ml of SOC (2% Bacto tryptone, 0.5% Bacto yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgSO 4 , 20 mM glucose), incubated overnight at room temperature, and then spread onto agar to select kanamycin-resistant transformants, which should result from recombination between pHW1273 and the linear PCR product, and subsequent deletions of the upstream of icsB promoter region. After primary selection, mutants were maintained on medium without an antibiotic. They were colony purified once nonselectively at 42°C and then tested for chloramphenicol sensitivity to confirm the loss of the helper plasmid pKD46::Cm, which is temperature sensitive for replication.
For elimination of the kanamycin resistance genes of the recombinants, kanamycin-resistant mutants were transformed with pCP20, a chloramphenicol resistance plasmid that exhibits temperature-sensitive replication and thermal induction of FLP (flipase) synthesis, which causes recombination between FRT sequences. Chloramphenicol-resistant transformants were selected at 30°C, after which a few were colony purified once nonselectively at 42°C and then tested for loss of all antibiotic resistances. The majority lost the FRT-flanked kanamycin resistance gene on pHW1273 and the FLP helper plasmid pCP20 simultaneously. The resultant plasmids were derivatives of pHW1273 with deletions of icsB upstream regions.
SDS-PAGE and immunoblotting analysis. Whole-cell extracts of HW1273 and its derivatives (20 l) were subjected to electrophoresis under denaturing conditions. Proteins were separated by sodium dodecyl sulfate-12% polyacrylamide gel electrophoresis (SDS-12% PAGE) and then electrophoretically transferred to a polyvinylidene difluoride membrane. The membranes were blocked with 5% skim milk in phosphate-buffered saline containing 1% Tween 20 and then incubated with a 1:25,000 dilution of anti-IpaB serum (13) . Membranes were incubated with secondary horseradish peroxidase-conjugated anti-mouse immuno-FIG. 1. Primer extension mapping of the 5Ј end of transcript for icsB and alignment of 5Ј-end nucleotide sequence around translation initiation site of icsB. Total cellular RNAs were extracted from MC1061 harboring pHW735 (lane 1) and MC1061 harboring pHW735 and pHW749 (lane 2) grown in LB medium and annealed to the 32 P-labeled primer (5Ј-GAGGATCATACTTTATTAACTC-3Ј). DNA was synthesized by the reaction of reverse transcriptase. Lanes G, A, T, and C, standard sequence ladder synthesized by using the same primer and pHW735 DNA as the template. This indicates the sequence of the coding (non-RNA-like) strand, a part of which is shown in vertically ordered characters on the right. The arrow indicates the detected 5Ј end of icsB mRNA. Below the gel, the alignment of the 5Ј-end sequence of the noncoding (RNA-like) strand around the translation initiation site of icsB is shown. The nucleotide sequence is complementary to the S. sonnei pSS120 DNA sequence reported by Arakawa et al. (GenBank accession no. D50601). The hooked arrow at T-49 shows the 5Ј end of the icsB transcript on the noncoding strand. The Ϫ10 and Ϫ35 regions of a possible promoter are indicated by thick underlines. The horizontal arrow denotes the position and direction of the primer used in this experiment. The translation initiation site of icsB is A-139 in this figure, and the deduced amino acid sequence starting at this site is also indicated in the one-letter code. a Underlined sequences correspond to the flanking regions of the kanamycin resistance gene of pKD13 (7) . Dotted sequences correspond to the sites of the icsB promoter which flank regions to be deleted. The numbers indicate the position relative to the icsB transcription start site at ϩ1. globulin antibodies at a dilution of 1:20,000 and developed with the ECL kit (Amersham, London, United Kingdom). The signals were detected by exposure to X-ray film (Fuji, Tokyo, Japan) at room temperature.
Overproduction and purification of GST-InvE fusion protein. Plasmid pGEX-5X-3 (Amersham, London, United Kingdom) was used for expression and purification of InvE protein as a GST fusion protein (33) . A DNA fragment precisely corresponding to the reading frame of invE, starting at the initiation codon and ending at the termination codon, was synthesized by PCR with the primers 5Ј-CGGGATCCCCATGGTGGATTTGTGC-3Ј and 5Ј-GGCGAATTC CATCAGTGTTCGATGT-3Ј with BamHI and EcoRI linkers at the respective regions. This fragment was then digested with BamHI and EcoRI and ligated into the corresponding sites of pGEX-5X-3. The resultant plasmid was designated pQW2001. MC1061 harboring pQW2001 was cultured to an optical density at 600 nm of approximately 0.5. After addition of isopropyl-␤-D-thiogalactopyranoside (IPTG) to a final concentration of 1 mM to induce expression of the cloned fusion gene, culturing proceeded until an optical density at 600 nm of 1.0 was reached. Then the cells were harvested by centrifugation, suspended in the lysis buffer described above, frozen at Ϫ20°C, and thawed. After 3 min of sonication, soluble crude extract was obtained by centrifugation.
A 10-ml sample of this extract was absorbed into a 0.4-ml glutathione-Sepharose 4B gel (Pharmacia) previously equilibrated with phosphate-buffered saline. The gel was washed extensively with the above buffer, and bound proteins were then eluted twice with 0.2 ml of the elution buffer described above at 4°C for 1 h. Protein concentration was determined with a protein assay kit (Bio-Rad). The protein was stored at Ϫ70°C.
Gel mobility shift assay. A DNA fragment carrying the regulatory region upstream of the icsB-ipa operon was used as the probe. The double-stranded DNAs used for probes were amplified by PCR or made from complementary synthetic oligonucleotides (ESPEC Oligo Service Co., Tokyo, Japan) and labeled with digoxigenin (DIG)-11-ddUTP (Roche Diagnostics) with 1 U of terminal deoxynucleotidyl transferase at 37°C for 30 min in a solution of 200 mM potassium cacodylate, 25 mM Tris-HCl (pH 6.6), 0.25 mg of bovine serum albumin per ml, and 5 mM CoCl 2 . After the labeling reaction, the probes were precipitated with ethanol, suspended in H 2 O, and stored at Ϫ20°C. Eight femtomoles of each DIG-labeled probe was incubated with the GST-InvE sample at 25°C for 30 min in a final volume of 20 l containing 20 mM HEPES (pH 7.6), 1 mM EDTA, 10 mM (NH 4 ) 2 SO4, 1 mM dithiothreitol, 0.2% (wt/vol) Tween 20, 30 mM KCl, 50 ng of poly(dI-dC) per l, and 5 ng of poly-L-lysine per l. After the addition of 5 l of 0.25ϫ Tris-borate-EDTA (TBE) containing 40% glycerol, incubated samples were run on a 6% polyacrylamide gel (79:1) in 0.25ϫ TBE, followed by electroblotting onto a nylon membrane (Hybond-Nϩ; Amersham, London, United Kingdom) and fixation by UV cross-linking. Detection of DNA fragments by anti-DIG Fab fragment-alkaline phosphatase conjugate (Roche Diagnostics) and substrate CSPD (Tropix Inc.) was performed as directed by the manual from the manufacturer (Roche Diagnostics). The signals were recorded by exposure to X-ray film (Fuji, Tokyo, Japan) at room temperature.
RESULTS
Determination of transcription start site and transcriptional regulation of icsB mRNA. In a previous study, we reported that both InvE and VirF are required for expression of the ipaBCD genes encoded on the large plasmid of S. sonnei and suggested that the icsB-ipgABC-ipaBCD genes constitute an operon (ipa operon) (37) . In this study, we analyzed the predicted location of the ipa operon promoter, upstream of icsB, the leadoff gene of the ipa operon.
First, to precisely confirm the location of the promoter element, we determined the transcription initiation site of the ipa operon. We analyzed the icsB transcript by primer extension mapping in order to determine the transcription start site of icsB. The template RNAs were extracted from cultures of MC1061/pHW735 and MC1061/pHW735/pHW749. Both strains were grown in LB at 37°C, and RNAs prepared from the cultures were used for the experiment with a primer complementary to the icsB mRNA at nucleotides 126 to 147 (Fig. 1) . Table 2 . Nucleotide ϩ1 is the icsB transcription start site.
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PROMOTER ESSENTIAL FOR IpaB EXPRESSION 5161 90 bp upstream of the translation initiation codon of icsB (Fig.  1, lane 2) . Upstream of nucleotide T-49, the sequences TTATGT (Ϫ35 region) and TATGTT (Ϫ10 region) were found at nucleotides 10 to 15 and 36 to 41, respectively (Fig. 1) , and the distance between these two sequences was 20 bp. It should be pointed out that the promoter of the ipa operon has a Ϫ35 sequence and that the spacing between the Ϫ35 and Ϫ10 regions is also large (20 bp). These features perhaps justify the requirement for activators. This suggests that the extended band detected in this experiment corresponded to the transcription initiation site of icsB. The intensity of the band in the primer extension reaction with RNAs from the strain harboring pHW735 (neither virF or invE) was much lower than that of RNA from the strain harboring pHW735/ pHW749 (containing both virF and invE), although the same amount of RNA was used for the reactions (compare lanes 1 and 2 in Fig. 1 ). This is consistent with the observation that expression of icsB is dependent on the presence of both virF and invE at the transcriptional level.
Construction of promoter deletion series for ipa operon. Sasakawa et al. reported that there is promoter activity within the 1.9-kb HindIII fragment containing the translation start site of icsB (31) . However, the 1.9-kb HindIII sequence and VirF-InvE activators were not enough for full InvE-dependent activation. Then, in order to determine the essential cis-activating region upstream of the icsB gene, we used the large virulence plasmid pHW1273, which contains the whole region required for full expression of the ipa operon.
In order to define the promoter region that is necessary for ipa operon expression, we constructed mutants of the virulence plasmid of S. sonnei, pHW1273 to create a deletion series with Red recombinase as described in Materials and Methods. Strains carrying the parent plasmid pHW1273 and the deletion derivatives pTT0606, pTT0818, pTT1405, pTT1608, pTT1804, and pTT2002 (Fig. 2 ) in E. coli strain CC118 were designated HW1273, TT0606, TT0818, TT1405, TT1608, TT1804, and TT2002, respectively. For each strain, three independent transformants were chosen for PCR verification and sequencing. We confirmed the presence of the intact ipaB gene in all transformants by PCR. In each mutant, the deleted region was replaced by the nucleotides reported by Datsenko and Wanner (7) .
An 86-bp region upstream of the transcription start site of icsB is necessary for IpaB expression. In order to determine the effect of each deletion on IpaB expression, we used immunoblotting analysis with antiserum specific to IpaB. HW1273 harboring pHW1273 expressed IpaB protein, whereas TT0818, in which the region from Ϫ1740 to Ϫ41 (icsB transcription start site designated ϩ1) was deleted and which lacked the putative promoter region of the ipa operon, did not express IpaB (Fig. 3A, lanes 7 and 1) . In Fig. 3A , IpaB expression by HW1273, which contains the entire upstream region of icsB, was considered maximum expression. Deletion of the region from Ϫ1740 to Ϫ136 (TT0606) retained IpaB expression at the same level as HW1273 (Fig. 3A, lane 6) . These results showed that an important cis-acting region for IpaB expression was located between Ϫ136 and Ϫ41.
Mutant plasmids with further sequential deletions at 10-bp intervals between Ϫ136 and Ϫ41 were constructed with specially designed primers as described above. pTT1405, pTT1608, pTT1804, and pTT2002 lacked the nucleotides from Ϫ1740 to Ϫ74, Ϫ84, Ϫ94, and Ϫ104, respectively (Tables 1 and 2, Fig. 1 ). Deletion from Ϫ1740 to Ϫ84 (TT1608) reduced IpaB expression (Fig. 3A, lane 3) . However, deletion from Ϫ1740 to Ϫ94 (TT1804) retained IpaB expression at almost the same level as HW1273 (Fig. 3A, lane 4) . Next, we constructed sequential deletion mutants of the 10-bp stretch between Ϫ94 and Ϫ84 with the above method. The mutant plasmids pTT2201, pTT2202, and pTT2203 lacked the nucleotides from Ϫ1740 to Ϫ85, Ϫ86, and Ϫ87, respectively (Fig. 3B) . These deletion derivatives were used to transform E. coli strain CC118, creating strains designated TT2201, TT2202, and TT2203, respectively. Deletion from Ϫ1740 to Ϫ85 (TT2201) caused reduction of IpaB expression to an extent similar to that of TT1608 (Fig. 3C, lane 2) . Deletion from Ϫ1740 to Ϫ86 (TT2202) resulted in IpaB expression at a very low level (Fig. 3C, lane 3) . Deletion from Ϫ1740 to Ϫ87 (TT2203) resulted in IpaB expression at the same level as in HW1273 (Fig. 3C, lane 4) . Based on these findings, we hypothesized that the intact promoter of the ipa operon is located in the 86-bp region upstream of the transcription start site of icsB. At the 3Ј end of the region, we found the BoxA-like sequence 5Ј-ATGAAAT-3Ј (Ϫ83 to Ϫ77), which is known as a repeated motif of the ParB binding site in the parS region of plasmid P1 (9) . We named this sequence a ParB BoxA-like sequence. In conclusion, the ParB BoxA-like sequence and a further 3 bp (Ϫ86 to Ϫ84) were required for the full expression of IpaB. Next we examined whether InvE binding to the region was direct or not.
Direct binding of InvE to icsB upstream region. In order to clarify the mechanism by which InvE activates ipa operon expression, we determined whether the activation pathway is direct. First, we investigated the ability of InvE to bind to the DNA fragment corresponding to the icsB upstream region by gel shift assay. For this purpose, we purified GST-InvE as described in Materials and Methods. As shown in Fig. 4A , the specific PCR-amplified 150-bp DNA fragment, probe Q (from Ϫ143 to ϩ7, with the icsB transcription start site designated nucleotide ϩ1), was shifted upon addition of GST-InvE. The increased band shift was in proportion to the GST-InvE concentration. When the concentration of protein added to the reaction mixture was in the range of 0.3 to 9.6 M, only one shifted band was observed, suggesting that one DNA-protein complex was formed. Also, there was no retarded band for GST protein, the negative control (data not shown). Therefore, we searched for an InvE binding site(s) within this 150-bp region.
Based on the data from deletion mutants described above, 40-bp fragments (probe I, from Ϫ93 to Ϫ54; probe II, the same as probe I with altered sequences between Ϫ83 and Ϫ77; and probe III, the same as probe I with altered sequences between Ϫ63 and Ϫ54) were used as the target DNA in gel mobility shift experiments. The results of the assays with the GST-InvE sample and probes I, II, and III are shown in Fig. 4B . Probes I and III were clearly shifted when incubated with GST-InvE at FIG. 4 . Binding of GST-InvE to the putative ipa promoter region. (A) Eight femtomoles of probe Q (from Ϫ143 to ϩ 7, with the icsB transcription start site designated nucleotide ϩ 1) was synthesized by PCR, and the 3Ј terminus was labeled with DIG-11-ddUTP. The binding reaction mixtures are described in Materials and Methods and were incubated at 25°C for 30 min. The amounts of GST-InvE were 0, 0.3, 0.6, 1.2, 2.4, 4.8, and 9.6 M (lanes 1 to 7, respectively) in a final reaction volume of 20 l. To the left of the gel, the arrowhead indicates the position of protein-DNA complexes containing GST-InvE and probe Q. (B) Each probe was synthesized by the manufacturer (ESPEC Oligo Service Co., Tokyo, Japan); probe I consisted of Ϫ93 to Ϫ54 (lanes 1 and 2) , probe II consisted of the same sequence as probe I with an alteration of the ParB BoxA-like sequence from 5Ј-ATGA AAT-3Ј to 5Ј-CGTCCCG-3Ј (lanes 3 and 4) , and probe III consisted of the same sequence as probe I with an alteration of the Ϫ63 to Ϫ54 sequence from 5Ј-GCATATGTAG-3Ј to 5Ј-TACGCGTGCT-3Ј (lanes 5 and 6). The icsB transcription start site is designated nucleotide ϩ 1. Eight femtomoles of the probes at the 3Ј termini were labeled with DIG-11-ddUTP. Probes were incubated at 25°C for 30 min in the reaction mixture described in Materials and Methods in the absence of (Fig. 4B, lanes 2 and 6) , but probe II with the altered ParB BoxA-like region sequences was shifted little under the same condition (Fig. 4B, lane 4) . We also observed that the ParB BoxA-like sequence was conserved in the putative InvE binding regions upstream of the spa-15 and virA genes, which are regulated by InvE (Fig. 4C) . These results indicate that the ParB BoxA-like sequence is necessary for InvE binding.
DISCUSSION
InvE plays a central role in controlling expression of the virulence genes in Shigella spp., but little is known about the mechanism of transcriptional regulation. A recent study indicated that InvE has a DNA-binding function and interacts specifically with the putative promoter of the ipa operon (4). However, it has not been shown genetically whether the InvE binding site is essential for activation of the ipa operon in vivo, and the minimal cis region in the ipa promoter has not been determined. In this study, we used virulence plasmid pHW1273 for determination of the cis region essential for InvE-dependent activation.
First, we determined the transcription start site of ics-ipa. The transcription start site was located 90 bp upstream of the icsB translation initiation site, and sequences characteristic of E. coli promoters for 70 were found upstream of the transcriptional start site. The transcription of the mRNA was dependent upon InvE. These results suggest the presence of a cis region necessary for binding of InvE in addition to a conventional 70 promoter. To determine the cis region that is essential for ipa expression, we constructed a series of promoter deletions of virulence plasmid pHW1273 with a PCR-based gene disruption method and analyzed the IpaB expression of the mutants with antiIpaB antibody. The minimal region essential for full expression of the ipaB gene contained a 7-nucleotide sequence. The sequence (5Ј-ATGAAAT-3Ј) was homologous to a BoxA motif in the parS site of plasmid P1, which is required for specific DNA binding of the ParB protein (25) . Here we designated a ParB BoxA-like sequence. This finding is in good agreement with the fact that InvE protein has significant homology with ParB protein, especially the DNA binding domain (37) . The deletion mutants lacking the ParB BoxA-like sequence and two nucleotides in its vicinity lost the expression of IpaB, while strains maintaining the intact ParB BoxA-like sequence with three cytosine nucleotides showed full expression of IpaB. These results indicated that the ParB BoxA-like sequence and three cytosine residues in the vicinity were essential for the expression of the ipa operon. A study with Shigella flexneri showed binding of VirB (InvE) to various promoter regions (4) . These regions in S. sonnei also contain potential copies of the 7-bp ParB BoxA-like sequence [5Ј-(A/G)(A/T)G(G)AAA T-3Ј] (Fig. 4C) . This would strengthen the prediction about the binding specificity of VirB (InvE). These results led us to examine direct binding of InvE protein to the promoter region by gel shift assay.
GST-InvE protein bound to a region between nucleotides Ϫ93 and Ϫ54 (DNA probe I in Fig. 4B ) upstream of the icsB transcription start site at ϩ1. This region contained the ParB BoxA-like sequence. When the sequences of the ParB BoxAlike region were altered, the ability of GST-InvE to bind to the probe was reduced (Fig. 4B, lane 4) . This result again supports the hypothesis that InvE binding requires the ParB BoxA-like sequence in the ipa promoter region.
The identity of InvE and ParB is 42.8%, especially high in the predicted DNA binding motif (37) . The ParB HTH region recognizes the BoxA sequence on the parS site (35) . An HTH motif of InvE may also bind to the ParB BoxA-like sequence on the ipa promoter. However, nobody has shown whether ParB alone is sufficient for binding to the BoxA sequence, which seems to be the case with InvE. Further work is required to determine the possible cofactors that interact with InvE, which is competent for transcriptional activation of ipa genes. The present study provides a useful starting point for further study of transcriptional regulation by InvE.
